Rjet.com

ONCBIOMUNE PHARMACEUTICALS, INC. (OTCMKTS:OBMP) Files An 8-K Entry into a Material Definitive Agreement ITEM1.01 ENTRY INTO A MATERIAL DEFINITIVE AGREEMENT. The Contribution Agreement In furtherance of the previously disclosed term sheet, OncBioMune...

-Annual Recurring Revenue of $98.2 million, an increase of 16% over the fourth quarter of 2014. -Free Cash Flow of $8.5 million for the year ended December 31, 2015, as compared with free cash flow use of $8.1 million for the full year 2014. HOUSTON...

Eye on Iran: Sign of Thaw With Iran: American Cellphones Ringing in Tehran TOP STORIES Sign of Thaw With Iran: American Cellphones Ringing in Tehran | The New York Times Until recently, an American phone in Iran would not receive any signal. But that...

Today’s compendium of economic, political, and environmental events is a doozy. Starting with a taper at home we cover the latest developments in Europe, the Greek meltdown, Ukrainian angst and Russian manuvers, Latin American politics, Indian...

SOUTH SAN FRANCISCO, CA—(Marketwired – Sep 8, 2014) – Theravance Biopharma ( NASDAQ : TBPH ), through its US operating subsidiary, Theravance Biopharma US, Inc., today announced positive top–line results from its Phase 2b dose–ranging study of TD–42...